Prevalence of cytomegalovirus infection and its role in total immunoglobulin pattern in Iranian patients with different subtypes of multiple sclerosis

New Microbiologica

Volumn 34, Issue 3, 2011, Pages 263-274

  Sanadgol, Nima ^a   Ramroodi, Nourollah ^b   Ahmadi, Ghasem Ali ^c   Komijani, Majid ^d   Moghtaderi, Ali ^b   Bouzari, Majid ^e   Rezaei, Marzieh ^e   Kardi, Mohammad Taghi ^e   Dabiri, Soroush ^b   Moradi, Malek ^a   Sanadgol, Ehsan ^f  

^a UNIVERSITY OF ZABOL   (Iran)

^b ZAHEDAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c Dr Ahmadi Medical Laboratory   (Iran)

^d Hour Danesh Institute of Higher Education   (Iran)

^e UNIVERSITY OF ISFAHAN   (Iran)

^f MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Cytomegalovirus; Multiple sclerosis; PCR detection; Total antibodies

Indexed keywords

IMMUNOGLOBULIN; IMMUNOGLOBULIN E; IMMUNOGLOBULIN M;

ADOLESCENT; ADULT; ARTICLE; CYTOMEGALOVIRUS INFECTION; FEMALE; HUMAN; IMMUNOLOGY; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; POLYMERASE CHAIN REACTION; VIROLOGY;

ADOLESCENT; ADULT; CYTOMEGALOVIRUS INFECTIONS; FEMALE; HUMANS; IMMUNOGLOBULIN E; IMMUNOGLOBULIN M; IMMUNOGLOBULINS; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; POLYMERASE CHAIN REACTION; YOUNG ADULT;

CYTOMEGALOVIRUS;

EID: 84860397764     PISSN: 11217138     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. Andersson J. (1990). Cytomegalovirus infection in pregnancy. Scand. J. Infect. Dis. 71, 67-70.
2. Astegiano S., Sidoti F., Costa C., Ostorero A., Alotto D, Castagnou C., Bergallo M., Stella M., Cavallo R. (2010). Human cytomegalovirus load in fresh and glycerolized skin grafts. New Microbiol. 33, 253-256.
3. Barzilai O., Sherer Y., Ram M., et al. (2007). Epstein- Barr virus and cytomegalovirus in autoimmune diseases: are they truly notorious? A preliminary report. Ann. NY Acad. Sci. 1108, 567-577. (Pubitemid 47528770)
4. Bradwell A.R. (1995). IgG and IgA subclasses in disease. ISBN: 0704416239.
5. Browne E.R, Wing B., Coleman D., Shenk T. (2001). Altered cellular mRNA levels in human cy- tomegalovirus-infected fibroblasts: viral block to the accumulation of antiviral mRNAs. J. Virol. 75, 12319-12330. (Pubitemid 33115904)
6. Buljevac D., Flach H.Z., Hop W.C., Hudra D., Laman J.D., Savelkoul H.F., van Der Meche F.G., van Doorn P.A., Hintzen R.Q. (2002). Prospective study on the relationship between infections and multiple sclerosis exacerbations. Brain. 125, 952-960. (Pubitemid 34464607)
7. Cook S.D., Rohowsky-Kochan C., Bansil S., Dowling P.C. (1995). Evidence for multiple sclerosis as an infectious disease. Acta Neurol. Scand. (Suppl.) 161, 34-42.
8. Dyment D.A., Ebers G.C., Sadovnick A.D. (2004). Genetics of multiple sclerosis. Lancet Neurol. 3, 104- 110. (Pubitemid 38121313)
9. Erin E., McCandless, Robyn S., Klein (2007). Molecular targets for disrupting leukocyte trafficking during multiple sclerosis. Expert Reviews in Molecular Medicine. 9, 1-19. (Pubitemid 47215383)
10. Evers D.L., Wang X., Huang E.S. (2004). Cellular stress and signal transduction responses to human cytomegalovirus infection. Microbes Infect. 6, 1084- 1093. (Pubitemid 39233681)
11. Fischbach FT, Dunning MB III, eds. (2009) Manual of laboratory and diagnostic tests, 8th ed. Philadelphia: Lippincott Williams and Wilkins.
12. Freeman A.F., Holland S.M. (2008). The hyper-IgE syndromes. Immunol. Allergy Clin. North Am. 28, 277- 291, viii. (Pubitemid 351540841)
13. Gaeta A., Verzaro S., Latte M.C., Mancini C., Nazzari C. (2009). Diagnosis of neurological herpesvirus infections: real time PCR in cerebral spinal fluid analysis. New Microbiol. 32, 333-340.
14. Gilden D.H. (2005). Infectious causes of multiple sclerosis. Lancet Neurol. 4, 195-202. (Pubitemid 40269150)
15. Griffiths P.D. (2004). Cytomegalovirus, infection and immunity. Encyclopedia of Immunology. 722-724.
16. Hjelmesaeth J., Muller F., Jenssen T., et al. (2005). Is there a link between cytomegalovirus infection and new-onset posttransplantation diabetes mellitus? Potential mechanisms of virus induced beta-cell damage. Nephrol. Dial. Transplant. 20, 2311-2315. (Pubitemid 41548852)
17. Jacob C.M., Pastorino A.C., Fahl K., Carneiro-Sampaio M., Monteiro R.C. (2008). Autoimmunity in IgA deficiency: revisiting the role of IgA as a silent housekeeper. J. Clin. Immunol. 28, S56-S61.
18. Johnson R.T. (1994). The virology of demyelinating diseases. Ann. Neurol. 36, S54-D60.
19. Keegan B.M., Noseworthy J.H. (2002). Multiple sclerosis. Annu. Rev. Med. 53, 285-302. (Pubitemid 34182821)
20. Kishore J., Ghoshal U., Ghoshal U.C., et al. (2004). Infection with cytomegalovirus in patients with inflammatory bowel disease: prevalence, clinical significance and outcome. J. Med. Microbiol. 53, 1155- 1160. (Pubitemid 40052501)
21. Kurtzke J.F. (1993). Epidemiologic evidence for multiple sclerosis as an infection. Clin. Microbiol. Rev. 6, 382-427. (Pubitemid 23306593)
22. Larner A.J. (1986). Aetiological role of viruses in multiple sclerosis: a review. Journal of the Royal Society of Medicine. 79, 412-417. (Pubitemid 16077639)
23. Long C.M., Drew L., Miner R., Jekic-McMullen D., Impraim C., Kao S.Y.(1998). Detection of cy-tomegalovirus in plasma and cerebrospinal fluid specimens from human immunodeficiency virus infected patients by the AMPLICOR CMV test. J. Clin. Microbiol. 36, 2434-2438. (Pubitemid 28380932)
24. McMichael A.J., Hall A.J. (2001). Ultraviolet radiation and multiple sclerosis: time to shed more light. Neuroepidetniology. 20, 165-167. (Pubitemid 32718872)
25. Mehraein Y., Lennerz C., Ehlhardt S., et al. (2004). Latent Epstein-Barr virus (EBV) infection and cytomegalovirus (CMV) infection in synovial tissue of autoimmune chronic arthritis determined by RNA- and DNA-in situ hybridization. Mod. Pathol. 17, 781-789. (Pubitemid 38843360)
26. Michaux C., Morlat P., Bonnet F. (2010). Cytomegalovirus and other herpes virus infections in systemic diseases. La Presse Médicale. 39, 34-41.
27. Ochs H-D. (2008). Patients with abnormal IgM levels: assessment, clinical interpretation, and treatment. Ann. Allergy Asthma Immunol. 100, 509-511.
28. Olson J.K., Croxford J.L., Miller S.D. (2001). Virus- induced autoimmunity: potential role of viruses ininitiation, perpetuation, and progression of T-cell- mediated autoimmune disease. Viral Immunol. 14, 227-250. (Pubitemid 32852058)
29. Pan-Hammarstrom Q., Hammarstrom L. (2008). Antibody deficiency diseases. Eur. J. Immunol. 38, 327-333.
30. Panitch H.S. (1994). Influence of infection on exacerbations of MS. Ann. Neurol. 36, S25-8.
31. Polman C.H., Reingold S.C., Edan G, et al. (2005). Diagnostic criteria for multiple sclerosis: 2005 revisions to the "McDonald criteria". Ann. Neurol. 58, 840-846. (Pubitemid 41746873)
32. Richard C.G. Pollok. (2005). Cytomegalovirus. Encyclopedia of Gastroenterology. 543-544.
33. Richard J. Whitley (2003). Human herpes viruses. Encyclopedia of the Neurological Sciences. 595-596.
34. Sadovnick A.D., Dircks A., Ebers G.C. (1999). Genetic counseling in multiple sclerosis: risks to sibs and children of affected individuals. Clin. Genet. 56, 118-22. (Pubitemid 29433592)
35. Sambrook J., Fritsch E.F., Maniatis T. (1989). Molecular cloning: a laboratory manual. 2nd ed. New York: Cold Spring Harbor Laboratory Press. E3-E4.
36. Sellebjerg F., Barnes D., Filippini G., Midgard R., Montalban X., et al. (2005). EFNS guideline on treatment of multiple sclerosis relapses: report of an EFNS task force on treatment of multiple sclerosis relapses. Eur. J. Neurology. 12, 939-946. (Pubitemid 41820048)
37. Sinclair J., Sissons P. (1996). Latent and persistent infections of monocytes and macrophages. Inter. J. Virology. 39, 293-301. (Pubitemid 27174133)
38. Söderberg-NauclÉr C. (2008). CMV microinfections in inflammatory diseases and cancer. J. Clin. Virol. 41, 218-223.
39. Soldan S.S., Berti R., Salem N, Secchiero R, Flamand L., Calabresi RA., Brennan M.B., Maloni H.W., McFarland H.F., Lin H.C., Patnaik M., Jacobson S. (1997). Associated of human herpes virus 6 (HHV- 6) with multiple sclerosis. Nat. Med. 3, 1394-1397.
40. Stevenson V.L., Miller D.H., Rovaris M., Barkhof F., Brochet B, Dousset V., et al. (1999). Primary and transitional progressive MS. Neurology. 52, 839-845.
41. Su B.Y., Su C.Y., Yu S.F., et al. (2007). Incidental discovery of high systemic lupus erythematosus disease activity associated with cytomegalovirus viral activity. Med. Microbiol. Immunol. 196, 165-170. (Pubitemid 47300254)
42. Taylor-Wiedeman J., Sissons J.G., Borysiewicz L.K., et al. (1991). Monocytes are a major site of persistence of human cytomegalovirus in peripheral blood mononuclear cells. J. Gen. Virol. 72, 2059- 2064.
43. Tortorella D., Gewürz B.E., Furman M.H., Schust D.J., Ploegh H.L. (2000). Viral subversion of the immune system. Annu. Rev. Imunol. 18, 861-926. (Pubitemid 30365400)
44. Wandinger K., Jabs W, Siekhaus A., Bubel S.. Trillenberg P., Wanger H, Wessel K., Kirchner H, Hennig H. (2000). Association between clinical disease activity and Epsteine-Barr virus reactivation in MS. Neurology. 55, 178-184. (Pubitemid 30604615)
45. Yuki N., Yamamoto T., Hirahata K. (1998) Correlation between cytomegalovirus infection and IgM ant- MAG/SGDG antibody-associated neuropathy. Annal, of Neurology. 44, 408-410. (Pubitemid 28421450)